Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies.
Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies.
复制标题
DOI:
10.1016/j.jmsacl.2022.06.003
复制
发表时间:
2022-08
影响因子:
2.2
通讯作者:
Hoofnagle, Andrew N.
中科院分区:
文献类型:
--
作者:
Foulon, North;Goonatilleke, Elisha;MacCoss, Michael J.;Emrick, Michelle A.;Hoofnagle, Andrew N.
Simultaneous quantification of insulin and C-peptide without antibodies. Proteolysis with Glu-C permits sensitive and precise measurements. Calibration with certified reference material provides traceability. Relatively large bias when compared with a commercially available immunoassay. The measurement of insulin and C-peptide provides a valuable tool for the clinical evaluation of hypoglycemia. In research, these biomarkers are used together to better understand hyperinsulinemia, hepatic insulin clearance, and beta cell function. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an attractive approach for the analysis of insulin and C-peptide because the platform is specific, can avoid certain limitations of immunoassays, and can be multiplexed. Previously described LC-MS/MS methods for the simultaneous quantification of insulin and C-peptide measure the intact analytes and most have relied on immunoaffinity enrichment. These approaches can be limited in terms of sensitivity and interference from auto-antibodies, respectively. We have developed a novel method that does not require antibodies and uses proteolytic digestion to yield readily ionizable proteotypic peptides that enables the sensitive, specific, and simultaneous quantitation of insulin and C-peptide. Serum samples were precipitated with acetonitrile. Analytes were enriched using solid phase extraction and then digested with endoproteinase Glu-C. Surrogate peptides for insulin and C-peptide were analyzed using targeted LC-MS/MS. Inter-day imprecision was below 20 %CV and linearity was observed down to the lower limit of quantitation for both analytes (insulin = 0.09 ng/mL, C-peptide = 0.06 ng/mL). Comparison to a commercially available insulin immunoassay (Beckman Coulter UniCel DxI 600 Access) revealed a 30% bias between methods. A novel LC-MS/MS method for the simultaneous analysis of insulin and C-peptide using Glu-C digestion was developed and evaluated. A detailed standard operating procedure is provided to help facilitate implementation in other laboratories.
登录
查看更多内容
影响因子:
4.6
作者:
Robert T;Vanelle P;Brunet P;Martin N;Burtey S;Curti C
通讯作者:
Curti C
影响因子:
15.9
作者:
FABER, OK;HAGEN, C;ROSSING, N
通讯作者:
ROSSING, N
影响因子:
2.2
作者:
Dayaldasani, A.;Rodriguez Espinosa, M.;Perez Valero, V.
通讯作者:
Perez Valero, V.
影响因子:
9.3
作者:
Marcovina, Santica;Bowsher, Ronald R.;Steffes, Michael W.
通讯作者:
Steffes, Michael W.
影响因子:
2.2
作者:
Woo, W;LaGasse, JM;Hagopian, WA
通讯作者:
Hagopian, WA